Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The commercial agreement with Lonza follows the award of an Innovate UK grant to Synpromics announced on 23 April 2018. Lonza and Synpromics worked together to develop and test these innovative promoters in Lonza’s industry-leading GS Xceed® Expression System.
News
14 May 2019: Norwich Plant Bioscience Ltd (PBL) and Leaf Expression Systems Ltd (Leaf) are delighted to announce a further development in their relationship, with PBL granting Leaf the exclusive rights to sub-license the Hypertrans® transient expression system, the core technology underpinning Leaf’s biologics and vaccines contract development and manufacturing services business. Apart from rights previously granted to PBL’s pre-existing licensees, this effectively transfers to Leaf full control of the Hypertrans® technology and associated patented intellectual property.
Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical and healthcare sectors, has introduced a cell based bioassay service to meet rising demand for potency assessments.
In support of its continuing growth plans, Boyds, the leading consultancy business that supports the development of pharmaceutical and biotech products for patient benefit, has appointed a new CMC regulatory affairs professional.
Claire Scruton joins Boyds as Senior Manager of CMC Regulatory Affairs and will be based at the organisation’s Cambridge office.
Cell encapsulation for transport of cells and tissues at room temperature
Cambridge, UK and Newcastle, UK, 9th May 2019 / Sciad Newswire / Atelerix, creator of an innovative cell encapsulation technology, today announces it has closed a second round of funding of £700,000 to accelerate development of its cell transport products to market.
To support their ambitious growth plans, Dundee-based resourcing group Entrust Resource Solutions have acquired a second company, SCI Search and Selection, increasing their portfolio to three consultancies.
Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces dosing of the first patient in its Phase I clinical trial for its ultra-rapid acting insulin product candidate, AT247.
Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology, ArestatTM to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a collaboration with a new major global pharmaceutical partner.
Study compares two in vitro liver methods to determine which one best predicts BDIs